( MENAFN - Evertise Digital) The rising prevalence of chronic illnesses Such as diabetes, cancer, and cardiovascular diseases is Drive the demand for personalized treatment and point-of-care diagnostics. This, integrates with the development of advanced wearable biosensors and the integration of Internet of Things (IoT) technology in healthcare devices, is anticipated to be a key driver for the bioelectronics and biosensors market, propelling it to reach USD 65 billion by 2031 according to a report by SNS Insider. Growing Demand for Personalized Medicine and Point-of-Care Diagnostics The bioelectronics and biosensors market are experiencing significant growth due to the increasing demand for personalized medicine and point-of-care diagnostics.
Chronic illnesses are becoming more prevalent globally, placing a strain on healthcare systems. Personalized medicine offers a solution by tailoring treatment plans to individual patients based on their unique genetic makeup and health conditions. Biosensors play a Important role in personalized medicine by enabling continuous monitoring of vital signs and biomarkers, allowing for real-time adjustments to treatment plans.
The point-of-care diagnostics provide rapid and convenient testing options at doctors' offices or even in patients' homes, facilitating early detection and intervention for various diseases. Bioelectronics and biosensors offer a cost-effective and efficient way to address this need. Furthermore, the growing awareness o.
